NEW YORK (GenomeWeb News) – Luminex will be offering its molecular diagnostics directly to customers starting Jan. 1, 2013, the company said on Tuesday at its annual investor day conference.

The decision comes as Luminex's distribution deals with Abbott and Thermo Fisher Scientific expire at the end of this year and the Austin, Texas-based firm plans several new product launches in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.